A trial to assess the safety of nebulised heparin for acute lung injury

Phase 1

• Conditions: Acute lung injury; Respiratory - Other injuries and accidents

• Registration Number: ACTRN12606000388516
• Lead Sponsor: St Vincents Health Melboune

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2006-09-05
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Acute lung injurymechanical ventilation.

Exclusion Criteria

Systemic heparin administrationPulmonary haemorrhage.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Safety[All measured 1 hour after the nebulised drug is given.];Bleeding[All measured 1 hour after the nebulised drug is given.];Activated partial thromboplastin time[All measured 1 hour after the nebulised drug is given.]

Secondary Outcome Measures

Name	Time	Method
Alveolar dead space[Measured one hour after each episode of the nebulised drug.]